https://www.selleckchem.com/pr....oducts/sirpiglenasta
Therefore, new pharmaceutically active compounds, dimers, trimers, and hybrid molecules, could enhance the existing therapeutic alternatives in combating hematologic malignancies. Owing to the high potency and good tolerance without side effects of ARS-type drugs, combination therapies with standard chemotherapies could be applied in the future after further clinical trials in hematological malignancies. To explore whether a school-based water, sanitation and hygiene programme, which includes group hygiene activities, contributes
Мне нравится
Комментарий
Перепост
